flow study glp 1 Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the trial Mapping the effectiveness and risks

During the initial months of combination therapy, more frequent follow-up appointments are typically recommendedoften every 4-6 weeks

Sometimes people feel less hungry but eat the same amount out of habit, which undermines the protocol

It is a conversation to have with your prescriber, not something to pursue independently

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in patients prescribed Semaglutide

While no large trial has tested creatine specifically in GLP-1 users, the mechanism is relevant: creatine improves training performance, and better training performance means more muscle stimulus during a deficit